ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
生物医药B类股
555.788
+0.171
0.03%
手动刷新
涨家数:
16
跌家数:
17
平家数:
1
市盈率:
- -
高:
574.634
开:
560.699
低:
551.011
收:
555.617
数据加载中...
总览
新闻
中证香港中盘精选指数上涨0.72%,前十大权重包含康方生物等
金融界
·
昨天
A股突发!医疗器械配送巨头暴雷,身兼三职董事、董秘及副总裁的高管被留置,今年初陷入关联交易的质疑中
金融界
·
昨天
长春高新:子公司注射用伏欣奇拜单抗获批上市
格隆汇
·
昨天
【领航医药生物科技(00399.HK)拟更名为“星太链集团有限公司”及增加法定股本】智通财经APP讯,领航医药生物科技(
智通财经
·
昨天
MyStonks用户突破10000人,股票代币数量超146个
Odaily
·
昨天
昂利康:ALK-N001项目尚处于I期临床试验阶段
格隆汇
·
昨天
上半年QDII基金:最大涨幅86%,TOP10清一色重仓医药
蓝鲸财经
·
昨天
荣昌生物抉择新阶段,最高超40亿美元出海交易现“冷暖”
蓝鲸财经
·
昨天
上半年股票型基金业绩盘点:华安医药生物A狂飙66%,港股创新药ETF平均涨57%!煤炭光伏陷滑铁卢
新浪基金
·
昨天
研报掘金丨中邮证券:桂林三金盈利能力稳步提升,维持“买入”评级
格隆汇
·
昨天
大行评级|大摩:首予恒瑞医药H股目标价78港元及“增持”评级
格隆汇
·
昨天
【今海医疗科技(02225.HK)与戴维医疗(300314.SZ)订立合作框架协议】智通财经APP讯,今海医疗科技(02
智通财经
·
昨天
【复宏汉霖(02696.HK):获欧盟GMP证书】智通财经APP讯,复宏汉霖(02696.HK)发布公告,近日,公司全资
智通财经
·
昨天
贝达药业:盐酸恩沙替尼胶囊在澳门获批上市
格隆汇
·
昨天
【华润双鹤:复方氨基酸注射液(18AA-Ⅸ)获药品注册证书】华润双鹤公告,公司收到国家药监局颁发的复方氨基酸注射液(18AA-Ⅸ)《药品注册证书》。该药品适用于急、慢性肾功能不全患者出现低蛋白血症、低营养状态和手术前后的氨基酸补充。公司自2022年10月启动该药品的仿制药研发工作,于2023年10月20日提交上市许可申请,于2023年10月27日获得受理通知书,并于2025年6月24日获批上市。截至公告日,公司针对该药品累计研发投入为1074.35万元。根据全球71个国家药品销售数据库,2023年“Neoamiyu ”销售额为3220.56万美元。国内市场方面,2024年复方氨基酸注射液(18AA-Ⅸ)销售总额为1.2亿元人民币,广州绿十字制药有限公司占100%市场份额。
金融界
·
昨天
阳光诺和:签署STC007注射液技术开发(合作)合同,合同里程碑付款累计总金额为2亿元
格隆汇
·
昨天
华仁药业:全资子公司布美他尼原料药获上市批准
格隆汇
·
昨天
半程竞逐显实力!富国基金权益、固收、量化前10%的基金大盘点
新浪基金
·
昨天
每日卖空追踪 | 诺诚健华 07月02日卖空量成交185.3万股,卖空比例为10.17%
市场透视
·
昨天
每日卖空追踪 | 荣昌生物 07月02日卖空量成交24.95万股,卖空比例为1.77%
市场透视
·
昨天
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":555.78766,"timestamp":1751443682173,"preClose":555.61676,"halted":0,"volume":204532064,"delay":0,"changeRate":0.000308,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":0.170898,"latestTime":"07-02 16:00:00","open":560.6994,"high":574.63416,"low":551.0112,"amount":4510938942,"amplitude":0.042517,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1751506200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1751419800000,1751428800000],[1751432400000,1751443200000]],"pbRate":4.542016,"peRate":-27.978214,"turnoverRate":0.007685,"increases":17,"decrements":16,"flats":0,"marketCap":327266050176,"floatMarketCap":299340095920},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":574.63416,"amplitude":0.042517,"preClose":555.61676,"low":551.0112,"pbRate":"4.542016","latestPrice":555.78766,"volume":204532064,"delay":0,"open":560.6994,"prevYearClose":331.1933,"prevWeekClose":553.298,"prevMonthClose":555.617,"prevQuarterClose":555.617,"fiveDayClose":577.843,"twentyDayClose":491.473,"sixtyDayClose":483.207,"secType":"PLATE","market":"HK","turnoverRate":0.007685,"peRate":-27.978214,"marketCap":327266050176,"floatMarketCap":299340095920,"timestamp":1751443682173,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":16,"down":17,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548074816","title":"中证香港中盘精选指数上涨0.72%,前十大权重包含康方生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2548074816","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548074816?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 22:26","pubTimestamp":1751466398,"startTime":"0","endTime":"0","summary":"数据统计显示,中证香港中盘精选指数近一个月上涨7.01%,近三个月上涨9.97%,年至今上涨19.95%。据了解,中证香港中盘精选指数从香港市场选取中等规模的100只证券作为指数样本,以反映香港交易所上市中等规模证券的整体表现该指数以2004年12月31日为基日,以1000.0点为基点。从中证香港中盘精选指数持仓的市场板块来看,香港证券交易所占比100.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222343395340c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222343395340c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","LU1720050803.USD","LU0348783233.USD","LU0417516571.SGD","LU2488822045.USD","IE00B543WZ88.USD","BK1161","IE00B5MMRT66.SGD","09926","LU0348784397.USD","LU1794554557.SGD","BK1574"],"gpt_icon":0},{"id":"2548890216","title":"A股突发!医疗器械配送巨头暴雷,身兼三职董事、董秘及副总裁的高管被留置,今年初陷入关联交易的质疑中","url":"https://stock-news.laohu8.com/highlight/detail?id=2548890216","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548890216?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 21:40","pubTimestamp":1751463657,"startTime":"0","endTime":"0","summary":"金融界7月2日消息 A股突发,医疗器械配送巨头瑞康医药暴雷,董事、董秘及副总裁李喆被采取留置措施。2日晚间,瑞康医药突然公告称,公司董事、董事会秘书及副总裁李喆被济南市济阳区监察委员会实施留置措施。瑞康医药表示目前,公司拥有完善的治理结构和内部控制机制,除李喆外,其他董事、监事和其他高级管理人员均正常履职。","market":"sh","thumbnail":"https://imgcloud.jrjimg.cn/2025/07/20250702213934584.png","type":0,"news_type":0,"thumbnails":["https://imgcloud.jrjimg.cn/2025/07/20250702213934584.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/07/02214051450601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["399300","159982","09997","BK1222","159883","09996","BK1583","BK1100","BK1574"],"gpt_icon":0},{"id":"2548892252","title":"长春高新:子公司注射用伏欣奇拜单抗获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2548892252","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548892252?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 20:56","pubTimestamp":1751460999,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["000661","BK0046","BK1515","03347","BK0057","BK1576","BK1141","BK1583","BK0028","09939","159938","BK0239","BK0188","BK0075","BK1161","BK1574"],"gpt_icon":0},{"id":"2548894977","title":"【领航医药生物科技(00399.HK)拟更名为“星太链集团有限公司”及增加法定股本】智通财经APP讯,领航医药生物科技(","url":"https://stock-news.laohu8.com/highlight/detail?id=2548894977","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548894977?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 20:22","pubTimestamp":1751458952,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159837","159938","BK1515","BK1161","BK1124","BK1574","09939","00399"],"gpt_icon":0},{"id":"2548704899","title":"MyStonks用户突破10000人,股票代币数量超146个","url":"https://stock-news.laohu8.com/highlight/detail?id=2548704899","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548704899?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 19:43","pubTimestamp":1751456625,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 数字资产交易平台 MyStonks 宣布,平台用户数量已突破 10000 人。同时,MyStonks 的股票代币数量也已超过 146 个,覆盖科技、金融、消费、医药、半导体、能源、航空及中概股等多个核心行业,并推出多只做空 ETF 代币。Mystonks 近期完成产品升级,优化了跨链资产转移的效率和市值数据的实时性,新增一周涨跌幅指标等。未来,MyStonks 计划推出基于美股市场的合约衍生品,满足市场多样化投资需求。\n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/437248?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK1515","159938","TTTN","159940","BK4585","BK1161","BK4588","BK4550","159582","159945","159231","09939","FDN","BK1574"],"gpt_icon":0},{"id":"2548899268","title":"昂利康:ALK-N001项目尚处于I期临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2548899268","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548899268?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 19:37","pubTimestamp":1751456225,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","159992","BK4008","BK1574","06978","002940","03347","BK0239","BK1161","ALK","BK1583","BK1576","BK4500","BK1141","BK4588"],"gpt_icon":0},{"id":"2548895332","title":"上半年QDII基金:最大涨幅86%,TOP10清一色重仓医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2548895332","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548895332?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 18:24","pubTimestamp":1751451880,"startTime":"0","endTime":"0","summary":"上半年,获得正收益的开放式基金19055只,占比86.26%;收益等于及大于20%的开放式基金899只,占比4.1%。如果进一步追踪分析,我们可以将观察范围缩小到开放式基金涨幅前20名,QDII基金涨幅前10名。目前,国内市场现存QDII基金677只,我们选取其上半年涨幅前10的基金进行比较分析。数据显示,这个涨幅TOP10榜单中,上半年最大涨幅86%,最小涨幅46.71%。一季报显示,在QDII基金涨幅TOP10榜单中,广发中证香港创新药ETF现有规模高达104.56亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1751365834330099753","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2548953308","title":"荣昌生物抉择新阶段,最高超40亿美元出海交易现“冷暖”","url":"https://stock-news.laohu8.com/highlight/detail?id=2548953308","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548953308?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 18:23","pubTimestamp":1751451795,"startTime":"0","endTime":"0","summary":"文|《投资者网》蔡俊荣昌生物在一个新阶段,再度出手。这一次,公司仍以出海为切入口。截至目前,公司市值约360亿元左右。百济神州的肿瘤药在海外热销,信达生物配股5.5亿美元并完成减肥药的获批上市。2024年推出新一轮定增计划,拟最高募集25.5亿元,之后调减至19.53亿元;截至今年6月,该方案仍处于上交所的审核阶段。不止如此,公司通过抵押各类资产向银行借款,截至今年一季度短期借款余额11.31亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1751426175234593076","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["09995","BK1161","LU2328871848.SGD","BK1574","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2548898401","title":"上半年股票型基金业绩盘点:华安医药生物A狂飙66%,港股创新药ETF平均涨57%!煤炭光伏陷滑铁卢","url":"https://stock-news.laohu8.com/highlight/detail?id=2548898401","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548898401?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:45","pubTimestamp":1751449500,"startTime":"0","endTime":"0","summary":" 2025年上半年,A股市场呈现出鲜明的结构性行情,股票型基金业绩榜单成为这一趋势的生动注脚。Wind数据显示,截至二季度末,在涨幅前十的股票型基金中,医药生物主题基金占据多数席位。 被动指数产品方面,汇添富、银华、万家等机构旗下的4只港股通创新药ETF同步跻身前十,平均涨幅达57.2%,成为上半年被动投资领域最大亮点。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-07-02/doc-infeasqh2420736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","161032","150257","513120","BK1161","BK1574","09939","BK1515"],"gpt_icon":0},{"id":"2548867226","title":"研报掘金丨中邮证券:桂林三金盈利能力稳步提升,维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867226","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548867226?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:23","pubTimestamp":1751448182,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["161027","159938","BK1515","BK1161","BK1574","09939","002275","BK0239","BK0028","BK0188","BK0060"],"gpt_icon":0},{"id":"2548862465","title":"大行评级|大摩:首予恒瑞医药H股目标价78港元及“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548862465","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548862465?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:15","pubTimestamp":1751447715,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1064131003.USD","BK0060","BK0012","LU2495084118.USD","399300","LU1655091616.SGD","LU1064130708.USD","BK1191","LU0405327494.USD","LU2488822045.USD","BK0196","LU1997245094.SGD","600276","01276","BK1161","BK0183","159982","LU1997245177.USD","BK1574","LU1328615791.USD","LU1969619763.USD","06978","LU2148510915.USD","LU1997244956.HKD","LU2328871848.SGD","159992","LU0405327148.USD","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2548862982","title":"【今海医疗科技(02225.HK)与戴维医疗(300314.SZ)订立合作框架协议】智通财经APP讯,今海医疗科技(02","url":"https://stock-news.laohu8.com/highlight/detail?id=2548862982","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548862982?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:07","pubTimestamp":1751447242,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","159883","09996","159891","BK0251","BK1574","BK1150","BK0046","09997","BK0042","BK1583","02225","BK1222","300314","BK0048"],"gpt_icon":0},{"id":"2548286268","title":"【复宏汉霖(02696.HK):获欧盟GMP证书】智通财经APP讯,复宏汉霖(02696.HK)发布公告,近日,公司全资","url":"https://stock-news.laohu8.com/highlight/detail?id=2548286268","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548286268?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:05","pubTimestamp":1751447124,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","US6M.BOND","09939","161726","159938","BK1574","US10Y.BOND","US30Y.BOND","US3Y.BOND","US12M.BOND","US2Y.BOND","FESXmain","FSXEmain","US5Y.BOND","BK1161","02696","US7Y.BOND","399441"],"gpt_icon":0},{"id":"2548864757","title":"贝达药业:盐酸恩沙替尼胶囊在澳门获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2548864757","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548864757?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:01","pubTimestamp":1751446880,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159992","06978","BK4500","BK0060","BK4585","ALK","BK1161","BK0239","BK4588","BK1574","300558","BK4008"],"gpt_icon":0},{"id":"2548864134","title":"【华润双鹤:复方氨基酸注射液(18AA-Ⅸ)获药品注册证书】华润双鹤公告,公司收到国家药监局颁发的复方氨基酸注射液(18AA-Ⅸ)《药品注册证书》。该药品适用于急、慢性肾功能不全患者出现低蛋白血症、低营养状态和手术前后的氨基酸补充。公司自2022年10月启动该药品的仿制药研发工作,于2023年10月20日提交上市许可申请,于2023年10月27日获得受理通知书,并于2025年6月24日获批上市。截至公告日,公司针对该药品累计研发投入为1074.35万元。根据全球71个国家药品销售数据库,2023年“Neoamiyu ”销售额为3220.56万美元。国内市场方面,2024年复方氨基酸注射液(18AA-Ⅸ)销售总额为1.2亿元人民币,广州绿十字制药有限公司占100%市场份额。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548864134","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548864134?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:56","pubTimestamp":1751446615,"startTime":"0","endTime":"0","summary":"截至公告日,公司针对该药品累计研发投入为1074.35万元。根据全球71个国家药品销售数据库,2023年“Neoamiyu ”销售额为3220.56万美元。国内市场方面,2024年复方氨基酸注射液销售总额为1.2亿元人民币,广州绿十字制药有限公司占100%市场份额。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/02165651440871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK0028","BK0010","BK0239","01477","BK0185","BK0188","BK0175","BK1574","600062"],"gpt_icon":0},{"id":"2548686499","title":"阳光诺和:签署STC007注射液技术开发(合作)合同,合同里程碑付款累计总金额为2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548686499","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548686499?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:54","pubTimestamp":1751446447,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4134","BK1515","688621","03347","159938","BK1141","BK1576","09939","BK1161","BK1583","III","BK0216","BK1574"],"gpt_icon":0},{"id":"2548986451","title":"华仁药业:全资子公司布美他尼原料药获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2548986451","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548986451?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:49","pubTimestamp":1751446159,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1222","BK1574","BK1100","BK1191","BK1583","300110","09996","BK0102","09997","BK0239","159883","01477"],"gpt_icon":0},{"id":"2548308864","title":"半程竞逐显实力!富国基金权益、固收、量化前10%的基金大盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2548308864","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548308864?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:36","pubTimestamp":1751445360,"startTime":"0","endTime":"0","summary":"2025上半年,A股市场整体呈现“N型”走势。作为国内首批成立的“老十家”公募基金公司之一,富国基金依托成熟的投资理念和深厚的投研积淀,在权益、固收、量化等核心领域持续深耕细作,旗下多只产品业绩持续位居同类前列,为投资者提供了穿越周期的多元化资产配置解决方案。 银河证券数据显示,截至2025年6月30日,富国基金旗下11只权益类基金近一年业绩位居同类前10%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2025-07-02/doc-infeanhh5749942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2548709898","title":"每日卖空追踪 | 诺诚健华 07月02日卖空量成交185.3万股,卖空比例为10.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548709898","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548709898?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:30","pubTimestamp":1751445045,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间07月02日,跌1.07%,卖空量成交185.3万股%,较上一交易日减少2.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172528a4cae02e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172528a4cae02e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09969","BK1574"],"gpt_icon":0},{"id":"2548607408","title":"每日卖空追踪 | 荣昌生物 07月02日卖空量成交24.95万股,卖空比例为1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548607408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548607408?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 16:30","pubTimestamp":1751445045,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间07月02日,涨1.47%,卖空量成交24.95万股%,较上一交易日减少55.76%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172528a72a4b94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172528a72a4b94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1161","09995","LU2328871848.SGD","BK1583","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":1,"totalSize":791,"code":"91000000","status":"200"}]}}